ÎÛÎÛ²ÝÝ®ÊÓƵ

Metabolomics Innovation Resource (MIR)

ÎÛÎÛ²ÝÝ®ÊÓƵ

A metabalomics laboratory

About

The Metabolomics Innovation Resource (MIR) at the Goodman Cancer Institute (GCI) is the primary node of a three-facility network (GCI, U Ottawa, Van Andel Research Institute) that specializes in metabolism and the measurement of small molecule metabolites. MIR is a multi-platform facility equipped with mass spectrometry, Seahorse (in-vivo respiration), and Nova Bioprofiling instrumentation. In addition to standard metabolite characterization, highly experienced platform scientists develop new technologies in response to researchers’ needs and offer workshops and one-on-one training to their users.

Ìý

Ìý

Leadership Team

Peter Seigl mcgill university 2022

Scientific Director

Peter Siegel, PhD

daina avizonis mcgill university 2022

Platform Manager

Daina Avizonis, PhD

Ìý

Tags:Ìý Metabolomics Core Facility, ÎÛÎÛ²ÝÝ®ÊÓƵ Goodman Cancer Institute, GCI, Agilent, Bruker, NMR, GC/MS, LC-MS, LC-MS/MS, Seahorse XFe24, Seahorse XFe96, Seahorse Xfp, BioProfile 400

Back to top